CD8A and cancer: According to IHC results of CD8+ in animal transplanted cancer samples, mice in the LINC01592-OE groups expressed obviously less CD8+; however, the phenomenon could be reversed by knocking down NBR1 while overexpressing LINC01592 (Figs. 7F-G).